article · Frontiers in Oncology

SLNP-based CDK4- targeted nanotherapy against glioblastoma

Uzma Ghani
Fareeha Khalid Ghori
Saira Justin
Mohammed Bourhia
Sabahat Habib
Basit Azad
Hina Khan
Gamal A. Shazly
Tawaf Ali Shah
Muhammad Usman Qamar
Ishaq Khan
Fouzia Perveen
Aneela Javed

20242 citationsOpen accessUniversité Ibn Zohr

Abstract

Our results indicated that Sil and SLNP-Sil are promising therapeutic approaches against glioblastoma and merit <i>in vivo</i> experimental verification using orthotropic xenograft mouse models against glioblastoma.

Research topics

Nanoparticle-Based Drug Delivery
Retinoids in leukemia and cellular processes
Cancer therapeutics and mechanisms

Sustainable Development Goals

Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.3389/fonc.2024.1455816

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.